Yıl 2018, Cilt 4, Sayı 4, Sayfalar 231 - 246 2018-10-01

İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ
IMMUNOTHERAPY AND POTENTIAL USE OF PROPOLIS IN CANCER IMMUNOTHERAPY

Elif Onur [1] , Ayşe Nalbantsoy [2] , Duygu Kışla [3]

73 426

Son yıllarda kanser hastalığı oldukça yaygın olarak görülmektedir. Halk sağlığı için büyük tehlike oluşturan kanser hastalığının tedavi yöntemleri üzerinde yenilikçi araştırmalar yapılmaktadır. İmmünoterapi immün yanıtları artıran veya azaltan terapötik ajanlar ile ortaya çıkan hastalığın tedavisidir. İmmünoterapinin kanser tedavisinde etkili olduğu bilinmektedir. Bu amaç doğrultusunda kullanılabilirliği araştırılan, bir arı ürünü olan propolis antitümör etkiler göstermesi ile dikkat çekmektedir. Bunun yanı sıra antibakteriyel, antimikrobiyal, antifungal, antiviral ve sitotoksik etkileri olduğu bilinmekte olan propolisin son yıllarda immünomodülatör etkileri incelenmektedir. Araştırmacılara göre propolis kanser immünoterapisinde umut vadeden bir bileşendir. Bu derlemede immünoterapi ve propolisin kanser immünoterapisinde kullanımı hakkında bilgi verilmesi amaçlanmaktadır.

In recent years cancer incidence has increased. Innovative studies have been carried out on the treatment methods of cancer, a major threat to public health. Immunotherapy is the treatment of the disease with therapeutic agents that increase or decrease immune responses. Immunotherapy is known to be effective in the treatment of cancer. A bee product, propolis that has been investigated for its availability in this respect draws attention because of its antitumor effects. In addition, immunomodulatory effects of propolis, which is known to have antibacterial, antimicrobial, antifungal, antiviral and cytotoxic effects, have been investigated in recent years. According to researchers, propolis is a promising compound in cancer immunotherapy. In this review, it is aimed to give information about immunotherapy and the use of propolis in cancer immunotherapy.

  • Akramiené, D., Kondrotas, A., Didžiapetriené, J., Kévelaitis, E. (2007). Effects of β-glucans on the Immune System. Medicisa (Kaunas), 43(8), 597-606.
  • Arda, M., Minbay, A., Aydın, N., Akay, Ö., İzgür, M., Diker, S. (1998). İmmunoloji. Ankara: Medisan Yayınevi, p. 20-31.
  • Atayoğlu, T. (2012). Apiterapi Açısından Arı Ürünlerinin Kalite Kriterleri ve Standardizasyonu. Standard Ekonomik ve Teknik Dergi, 601, 68-73.
  • Awale, S., Li, F., Onozuku, H., Esumi, H., Tezuka, Y., Kadota, S. (2008). Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition. Bioorganic and Medicinal Chemistry, 16, 181-189.
  • Bankova, V. (2005). Recent trends and important developments in propolis research. Evidence-based Complementary and Alternative Medicine, 2, 29-32.
  • Banskota, A. H., Tezuka, Y., Kadota, S. (2001). Recent progress in pharmacological research of propolis. Phytotherapy Research,, 15, 561-571.
  • Barbaros, B., Dikmen, M. (2015). Kanser İmmünoterapisi. Erciyes Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 31(4), 177-181.
  • Barnes, S. (1997). The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Research Treament (46), 169–179.
  • Bazo, A.P., Rodrigues, M.A.M., Sforcin, J.M., Camargo, J.L.V., Ribeiro, L.R., Salvadori, D.M.F. (2002). Protective action of propolis on the rat colon carcinogenesis. Teratogenesis, Carcinogenesis and Mutagenesis, 22, 183-194.
  • Boudourova-Krasteva, G., Bankova, V., Sforcin, J. M., Nikolova, N., Popov, S. (1997). Phenolics from Brazilian propolis. Zeitschrift für Naturforschung 52, 676-679.
  • Burdock, G.A. (1998). Review of the biological properties and toxicity of bee propolis (propolis). Food and Chemical Toxicology, 36, 347–363.
  • Carvalho, A.A., Finger, D., Machado, C.S., Schmidt, E.M., Costa, P.M., Alves, A.P.N.N., Morais, T.M.F., Queiroz, M.G.R., Quináia, S.P., Rosa, M.R., Santos, J.M.T., Pessoa, C., Moraes, M.O., Lotufo, L.V.C., Sawaya, A.C.H.F., Eberlin, M.N., Torres, Y.R. (2011). In vivo antitumoural activity and composition of an oil extract of Brazilian propolis. Food Chemistry, 126, 1239-1245.
  • Chan, G.C., Chan, W.K., Sze, D.M. (2009). The Effects of β-Glucan on Human, Immune and Cancer Cells. Journal of Hematology and Oncology, 25(2), 1-11. Chen, C.N., Weng, M.S., Wu, C.L., Lin, J.K. (2014). Comparison of Radical Scavenging Activity, Cytotoxic Effects and Apoptosis Induction in Human Melanoma Cells by Taiwanese Propolis from Different Sources. Evidenced-based Complementary and Alternative Medicine, 1(2), 175-185.
  • Choudhari, M.K., Haghniaz, R., Rajwade, J.M., Paknikar, K. (2013). Anticancer Activity of Indian Stingless Bee Propolis: An In Vitro Study. Evidence-Based Complementary and Alternative Medicine, Volume 2013, 1-10.
  • Cuesta, A., Rodriguez, A., Angeles, M. (2005). In vivo effects of propolis, a honeybee product, on gilthead seabream innate immune responses. Fish and Selfish Immun, 18(1), 71-80.
  • DeCastro, S.L. (2001). Propolis: biological and pharmacological activities. Therapeutic uses of this bee-product. Annual Review of Biomedical Science (3), 49-83.
  • DeSantes, K.B., Sondel P.M., Orkin, S.H., Fisher, D.E., Look, A.T., Lux, S.E., Ginsburg, D., Nathan, D.G. (2009). Immunotherapy of Cancer, Oncology of Infancy and Childhood, 209-241.
  • Doğan, N., Hayoğlu, İ. (2012). Propolis ve kullanım alanları, Harran Üniversitesi, Ziraat Fakültesi Dergisi, 16(3), 39-48.
  • Dudov, I.A., Morenets, A.A., Artiukh, V.P., Starodub, N. F. (1994). Immunomodulatory effect of honeybee flower pollen load, Ukrainskii Biokhimicheskii Zhurnal, 66(6), 91-93.
  • Filho, R.N.P., Batista, F.S., Ribeiro, D.R., Melo, G.C., Reis, F.P., Melo, A.U.C., Gomes, M.Z., Cardoso, J.C., Albuquerque, R.L.C. (2014). Chemopreventive Effect of Brazilian Green Propolis on Experimental Dermal Carcinogenesis in Murine Model. International Journal of Morphology, 32(2), 522-530.
  • Gardana, C., Barbieri, A., Simonetti, P., Guglielmetti, S. (2012). Biotransformation strategy to reduce allergens in propolis. Applied and Environmental Microbiology, 78(13), 4654-4658.
  • Ghisalberti, E.L. (1979). Propolis: a review. Bee World, 60, 59–84.
  • Göç, D. (2015). Tümörlere ve Nakil Dokularına Karşı İmmün Yanıtlar. In Y. Camcıoğlu ve G. Deniz (Eds.), Temel İmmünoloji, İmmün Sistemin İşlevleri ve Bozuklukları. (p. 189-205). Ankara, Güneş Tıp Kitapevi.
  • Grunberger, D., Banerjee, R., Eisinger, K., Oltz, E.M., Efros, L., Caldwell, M., Estevez, V., Nakanishi, K. (1988). Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis, Experientia, 44, 230-232.
  • Hausen, B. M. (2005). Evaluation of the main contact allergens in propolis. Dermatitis, 16(3), 127-129.
  • Hepşen, İ.F. Tilgen, F., Er, H. (1996). Propolis: Tıbbi ve Oftalmolojik Kullanımı. Turgut Özal Tıp Merkezi Dergisi 3(4), 386-391.
  • Herbert, T.B. Cohen, S. (1993). Stress and Immunity in Humans: A Meta-Analytic Review, Psychosomatic Medicine, 55, 364-379.
  • Holick, M.F., Garabedian, M. (2006). Vitamin D photobiology, metabolism, mechanism of action and clinical application. Washington, p. 106-114.
  • Huang, S., Zhang, C.P., Wang, K., Li, G.Q., Hu, F.L. (2014). Recent Advances in the Chemical Composition of Propolis. Molecules, 19(12), 19610-19632.
  • Inoue, K., Saito, M., Kanai, T., Kawata, T., Shigematsu, N., Uno, T., Isobe, K., Liu, C. H., Ito, H. (2008). Anti-Tumor Effects of Water-Soluble Propolis on a Mouse Sarcoma Cell Line In Vivo and In Vitro. The American Journal of Chinese Medicine, 36 (3), 625-634.
  • Jantan, I., Ahmad, W., Bukhari, S.N.A. (2015). Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Frontiers in Plant Science, 6, 1-18.
  • Jasprica, I., Mornar, A. Debeljak, Z., Bubalo, A.A., Sari´c, M., Mayerc, L., Romi´c, Z., Bucan, K., Balog, T., Sobocanec, S., Sverko, V. (2007). In vivo study of propolis supplementation effects on antioxidative status and red blood cells. Journal of Ethnopharmacology 110, 548-554.
  • Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., Forman, D. (2011). Global Cancer Statistic. Cancer Journal for Clinicians, 61, 69-90.
  • Jones, A., McAdam, M., Rayter. Z., Mansi, J. (2003). Medical Therapy of Advanced Disease. Medical Therapy of Breast Cancer, 283-308.
  • Jutel, M., Pichler, W.J., Skrbic, D., Urwyler, A., Dahinden, C., Müller, U. R. (1995). Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. Journal of Immunol, 154(8), 4187-4194.
  • Kaneno, R. (2005). Role of natural killer cells in antitumor resistance. Annual Review of Biomedical Sciences, 7, 127–148.
  • Kimoto, T., Arai, S., Kohguchi, M., Aga, M., Nomura, Y., Micallef, M. J., Kurimoto, M., Mito, K. (1998). Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis. Cancer Detection and Prevention, 22, 506-515.
  • Kumova, U., Korkmaz, A., Avcı, B.C., Ceyran, G. (2002). Önemli bir arı ürünü: Propolis, Uludağ Arıcılık Dergisi, 22-28.
  • Kundu, J. K., Surh, Y. J. (2008). Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Letters, 269, 243-261.
  • Lee, Y.T., Don, M.J., Hung, P.S., Shen, Y.C., Lo, Y.S., Chang, K.W., Chen, C.F., Ho, L.K. (2005). Cytotoxic of phenolic acid phenethyl esters on oral cancer cells. Cancer Letters, 223, 19-25.
  • Li, Y., Sarkar, F.H. (2002). Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Letters, 186, 157-164.
  • Liao, H.F., Chen, Y.Y., Liu, J.J., Hsu, M.L., Shieh, H.J., Liao, H.J., Shieh, C.J., Shiao, M.S., Chen,Y.J. (2003). Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. Journal of Agricultural and Food Chemistry, 51, 7907–7912.
  • Lisicic, D., Benkovic, V., Dikic, D, Blazevic, A.S., Mihaljevic, J., Orsolic, N., Knezevic, A.H. (2014), Addition of Propolis to Irinotecan Therapy Prolongs Survival in Ehrlich Ascites Tumor-Bearing Mice. Cancer Bıotherapy and Radıopharmaceutıcals, 29(2), 62-69.
  • Maksimova-Todorova, V., Manolova, N., Gegova, G. (1985). Antiviral action of some fractions isolated from propolis. Acta Microbiologica Bulgarica, 17, 79-84.
  • Marcucci, M.C. (1995). Propolis: chemical composition, biological properties and therapeutic activity. Apidologie (26), 83-99.
  • Markham, K.R., Mitchel, K.A., Wilkins, A.L., Daldy, J.A., Lu, Y. (1995). HPLC and GS-MS Identification of the Major Organic Constituents in New Zeland Propolis. Phytochemisty, 42(1), 205-211.
  • Matsuno, T. (1995). A new clerodane diterpenoid isolated from propolis. Zeitschrift für Naturforschung, 50, 93-97.
  • Matsuno, T., Chen, C., Basnet, P. (1997). A tumoricidal and antioxidant compound isolated from an aqueous extract of propolis. Medical Science Research, 25, 583-584.
  • Spesifik immün yanıtta hücre-hücre etkileşimleri, (31 Mart 2016) http://www.microbiologybook.org/Turkish-immunol/immunolchapter12turk.htm (Erişim tarihi: 24.08.2017)
  • Muehlbauer, P., Burke, M., Wilkes, G. (2006). Biologic Therapy for Cancer Treatments. Cancer Therapies, 117-180.
  • Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., Aggarwal, B.B. (2001). Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene, 20, 7597-7609.
  • Ning, Y., Xu, D., Zhang, X., Bai, Y., Ding, J., Feng, T., Wang, S., Xu, N., Qian, K., Wang, Y., Qi, C. (2016). β-Glucan Restores Tumor-Educated Dendritic Cell Maturation to Enhance Antitumor Immune Responses. International Journal of Cancer, 138, 2713-2723.
  • Niraula, N. P., Kim, S. H., Sohng, J. K., Kim, E. S. (2010). Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production. Applied Microbiology and Biotechnology, 87(4), 1187-1194.
  • Novak, E.M., Silva, M.S.C., Marcucci, M.C., Sawaya, A. C.H.F., López, B.G.C., Fortes, M.A.H.Z., Giorgi, R.R., Marumo, K.T., Rodrigues, R.F., Maria, D.A. (2014). Antitumoural activity of Brazilian red propolis fraction enriched with xanthochymol and formononetin: An in vitro and in vivo study. Journal of Functional Foods, 11, 91-102.
  • Orsolic, N., Knezevic, A.H., Sver, L., Terzic, S., Basic, I. (2004). Immunomodulatory and antimetastatic action of propolis and related polyphenolic compounds. Journal of Ethnopharmacology, 94, 307–315.
  • Orsolic, N., Terzic, S., Mihaljevic, Z., Sver, L., Basic, I. (2005). Effects of Local Administration of Propolis and Its Polyphenolic Compounds on Tumor Formation and Growth. Biological Pharmaceutical Bulletin, 28(10), 1928-1933.
  • Orsolić, N., Basić, I. (2005). Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP). Biomedicine and Pharmacotherapy, 59, (10), 561-570.
  • Osésa, S.M., Pascual-Matéa, A., Fernández-Muiño, M.A., López-Díaz, T.M., Sancho, M.T. (2016). Bioactive properties of honey with propolis. Food Chemistry, 196, 1215-1223.
  • Özbal, Y. (2000). Temel İmmünoloji. İstanbul: Nobel Tıp Kitabevleri, p. 18-110. ISBN: 9789752775602
  • Özverel, C.S., Karaboz, İ., Nalbantsoy, A. (2017). Novel treatment strategies in cancer immunotherapy. Acta Biologica Turcica, 30(2), 36-51.
  • Park, J.H., Leea, J.K., Kima, H.S., Chunga, S.T., Eoma, J.H., Kima, K.A., Chunga, S.J., Paikb, S.Y., Oha, H.Y. (2004). Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. International Immunopharmacology, 4, 429-436.
  • Patel, S. (2016). Emerging Adjuvant Therapy for Cancer: Propolis and its Constituents. Journal of Dietary Supplements. 13(3), 245-268.
  • Pehlivan, T., Şahinler, N., Gül, A. (2012). Doğal bir ürün propolis; yapısı ve kullanım alanları, Arıcılık Araştırma Dergisi, 4(7), 9-13.
  • Pohorska, J., Richter, J., Kral, V., Dobiasova, L.R., Stiborova, I., Vetvicka, V. (2016). Reconstruction of NK Cells During Complex Cancer Treatment. Journal of Tumor, 4(2), 398-402.
  • Popovic, S., Baskic, D., Zelen, I., Djurdjevic, P., Zaric, M., Avramovic, D., Arsenijevic, N. (2012). The Cytotoxicity of Korbazol Against Murine Cancer Cell Lines. Serbian Journal of Experimental and Clinical Research, 13 (2), 62-67.
  • Rao, C. V., Desai, D., Rivenson, A., Simi, B., Amin, S., Reddy, B. S. (1995). Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Cancer Research, 55, 2310-2315.
  • Salatino, A., Teixeira, E.W., Negri, G., Message, D. (2005). Origin and chemical variation of Brazilian propolis. Evidence-based Complementary and Alternative Medicine, 2, 33-38.
  • Schenk, D. (2002). Amyloid-β immunotherapy for Alzheimer’s disease: the end of the beginning. Nature Reviews, 3, 824-828.
  • Sforcin, J.M. (2007). Propolis and the immune system: a review. Journal of Ethnopharmacology, 113, 1-14.
  • Sforcin, J.M., Funari, S.R.C., Novelli, E.L.B. (1995). Serum biochemical determinations of propolis-treated rats. The Journal of Venomous Animals and Toxins, 1, 31-37.
  • Sforcin, J. M., Kaneno, R., Funari, S. R. C. (2002). Absence of seasonal effect on the immunomodulatory action of Brazilian propolis on natural killer activity. The Journal of Venomous Animals and Toxins, 8, 19-29.
  • Singh, B. N., Shankar, S., and Srivastava, R. K. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical. Pharmacology, 82, 1807–1821.
  • Şengül, A. (2008). Hücresel İmmün Yanıt. Türkiye Klinikleri Enfeksiyon Hastalıkları Özel Dergisi, 1(2), 19-22.
  • Suzuki, I., Hayashi, I., Takaki, T., Groveman, D.S., Fujimiya, Y. (2002). Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. Cancer Biotherapy and Radiopharmaceuticals. 17(5), 553-562.
  • TS 12910 Arıcılık-Arı Tutkalı (Propolis), (14 Nisan 2003) https://intweb.tse.org.tr/standard/standard/Standard.aspx?053107106111065067115113049116090107100056052055108081090071086075069085047110067109075073081116103090081086073108065117084119102117080049106055054100083122117081090120069083101065078105117047 (Erişim tarihi: 10.07.2017)
  • Vagish Kumar, L.S. (2014). Propolis in Dentistry and Oral Cancer Management. North American Journal of Medical Sciences, 6(6), 250–259.
  • Van Etten, E., Mathieu, C. (2005). Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. The Journal of Steroid Biochemistry and Molecular Biology, 97, 93-101.
  • Viuda-Martos, M., Ruiz-Navajas, Y., Fernández-López, J., Pérez-Álvarez, J.A. (2008). Functional properties of honey, propolis, and royal jelly. Journal of Food Science, 73(9), 117-124.
  • Walgrave, S.E., Warshaw, E.M., Glesne, L.A. (2005). Allergic contact dermatitis from propolis. Dermatitis, 16, 209-215.
  • Wang, M., Yin, B., Wang, H.Y., Wang, R. (2014). Current Advances in T-Cell Based Cancer Immunotherapy, Future Medicine. Immunotherapy, 6(12), 1265-1278.
  • Whyte, L., Huang, Y.Y., Torres, K., Mehta, R.G. (2007). Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Research, 67, 12007-120017.
  • Yamaguchi, Y. (2016). Immunotherapy of Cancer: Overview of Current Cancer Immunotherapy. p. 3-21. Online ISBN 978-4-431-55031-0, ISBN 978-4-431-55030-3
  • Yılmaz, L., Yılsay, T.Ö., Bayizit, A.A. (2004). Propolisin Kimyasal Bileşimi, Biyolojik Özellikleri ve İnsan Sağlığı Üzerine Etkileri, Gıda ve Yem Bilimi Teknolojisi, 6, 34-38.
Birincil Dil tr
Konular Gıda Bilimleri ve Teknolojisi
Dergi Bölümü Makaleler
Yazarlar

Orcid: 0000-0002-5880-1340
Yazar: Elif Onur
Ülke: Turkey


Orcid: 0000-0002-3852-1974
Yazar: Ayşe Nalbantsoy
Kurum: EGE ÜNİVERSİTESİ, MÜHENDİSLİK FAKÜLTESİ, BİYOMÜHENDİSLİK BÖLÜMÜ
Ülke: Turkey


Orcid: 0000-0002-6993-3883
Yazar: Duygu Kışla (Sorumlu Yazar)
Kurum: EGE ÜNİVERSİTESİ, MÜHENDİSLİK FAKÜLTESİ, GIDA MÜHENDİSLİĞİ BÖLÜMÜ
Ülke: Turkey


Bibtex @derleme { jfhs350977, journal = {FOOD and HEALTH}, issn = {}, eissn = {2602-2834}, address = {ScientificWebJournals}, year = {2018}, volume = {4}, pages = {231 - 246}, doi = {10.3153/FH18023}, title = {İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ}, key = {cite}, author = {Onur, Elif and Kışla, Duygu and Nalbantsoy, Ayşe} }
APA Onur, E , Nalbantsoy, A , Kışla, D . (2018). İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ. FOOD and HEALTH, 4 (4), 231-246. DOI: 10.3153/FH18023
MLA Onur, E , Nalbantsoy, A , Kışla, D . "İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ". FOOD and HEALTH 4 (2018): 231-246 <http://jfhs.scientificwebjournals.com/issue/36388/350977>
Chicago Onur, E , Nalbantsoy, A , Kışla, D . "İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ". FOOD and HEALTH 4 (2018): 231-246
RIS TY - JOUR T1 - İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ AU - Elif Onur , Ayşe Nalbantsoy , Duygu Kışla Y1 - 2018 PY - 2018 N1 - doi: 10.3153/FH18023 DO - 10.3153/FH18023 T2 - FOOD and HEALTH JF - Journal JO - JOR SP - 231 EP - 246 VL - 4 IS - 4 SN - -2602-2834 M3 - doi: 10.3153/FH18023 UR - http://dx.doi.org/10.3153/FH18023 Y2 - 2018 ER -
EndNote %0 FOOD and HEALTH İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ %A Elif Onur , Ayşe Nalbantsoy , Duygu Kışla %T İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ %D 2018 %J FOOD and HEALTH %P -2602-2834 %V 4 %N 4 %R doi: 10.3153/FH18023 %U 10.3153/FH18023
ISNAD Onur, Elif , Nalbantsoy, Ayşe , Kışla, Duygu . "İMMÜNOTERAPİ VE PROPOLİSİN KANSER İMMÜNOTERAPİSİNDE KULLANIM POTANSİYELİ". FOOD and HEALTH 4 / 4 (Ekim 2018): 231-246. http://dx.doi.org/10.3153/FH18023